loadpatents
name:-0.067630052566528
name:-0.047629117965698
name:-0.037646055221558
Shah; Navnit H. Patent Filings

Shah; Navnit H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shah; Navnit H..The latest application filed is for "extended release compositions comprising trihexyphenidyl".

Company Profile
31.41.59
  • Shah; Navnit H. - Monmouth Junction NJ
  • SHAH; Navnit H. - Clifton NJ
  • Shah; Navnit H. - Bridgewater NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Programmable pharmaceutical compositions for chrono drug release
Grant 11,439,585 - Vaka , et al. September 13, 2
2022-09-13
Programmable pharmaceutical compositions for chrono drug release
Grant 11,419,813 - Vaka , et al. August 23, 2
2022-08-23
Extended Release Compositions Comprising Trihexyphenidyl
App 20220249377 - Shelke; Namdev B. ;   et al.
2022-08-11
Gastroretentive Dosage Forms Of Levodopa And Carbidopa
App 20220241184 - MEGHPARA; Kanji ;   et al.
2022-08-04
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20220218604 - Meghpara; Kanji ;   et al.
2022-07-14
Sustained Release Compositions Comprising Liothyronine
App 20220192977 - Vaghashiya; Jaydeep ;   et al.
2022-06-23
Delayed Release Methylphenidate Compositions
App 20220133635 - Vaka; Siva Ram Kiran ;   et al.
2022-05-05
Gastroretentive dosage forms for sustained drug delivery
Grant 11,318,091 - Meghpara , et al. May 3, 2
2022-05-03
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20220096366 - Vaka; Siva Ram Kiran ;   et al.
2022-03-31
Extended Release Compositions Comprising Pyridostigmine
App 20220096386 - Vaka; Siva Ram Kiran ;   et al.
2022-03-31
Delayed Release Compositions
App 20220079896 - Meghpara; Kanji ;   et al.
2022-03-17
Delayed Release Methylphenidate Compositions
App 20220040114 - Vaka; Siva Ram Kiran ;   et al.
2022-02-10
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20220031604 - Shah; Navnit H. ;   et al.
2022-02-03
Extended release compositions comprising pyridostigmine
Grant 11,229,606 - Vaka , et al. January 25, 2
2022-01-25
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210393512 - Vaka; Siva Ram Kiran ;   et al.
2021-12-23
Self-regulating osmotic gastroretentive drug delivery systems
Grant 11,179,320 - Shah , et al. November 23, 2
2021-11-23
Programmable pharmaceutical compositions for chrono drug release
Grant 11,166,906 - Vaka , et al. November 9, 2
2021-11-09
Extended Release Compositions Comprising Trihexyphenidyl
App 20210330657 - Shelke; Namdev B. ;   et al.
2021-10-28
Programmable pharmaceutical compositions for chrono drug release
Grant 11,154,494 - Vaka , et al. October 26, 2
2021-10-26
Extended release compositions comprising trihexyphenidyl
Grant 11,154,505 - Shelke , et al. October 26, 2
2021-10-26
Extended Release Compositions Comprising Pyridostigmine
App 20210236429 - Shelke; Namdev B. ;   et al.
2021-08-05
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20210236421 - Meghpara; Kanji ;   et al.
2021-08-05
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210228474 - Vaka; Siva Ram Kiran ;   et al.
2021-07-29
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210205207 - Vaka; Siva Ram Kiran ;   et al.
2021-07-08
Extended release compositions comprising trihexyphenidyl
Grant 11,045,420 - Shelke , et al. June 29, 2
2021-06-29
Extended release compositions comprising trihexyphenidyl
Grant 11,040,014 - Shelke , et al. June 22, 2
2021-06-22
High-concentration Fulvestrant Compositions
App 20210145846 - Shah; Navnit H. ;   et al.
2021-05-20
Gastroretentive dosage forms for sustained drug delivery
Grant 11,007,145 - Meghpara , et al. May 18, 2
2021-05-18
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20210137827 - Shah; Navnit H. ;   et al.
2021-05-13
Programmable pharmaceutical compositions for chrono drug release
Grant 11,000,471 - Vaka , et al. May 11, 2
2021-05-11
Extended release compositions comprising pyridostigmine
Grant 10,987,311 - Vaka , et al. April 27, 2
2021-04-27
Programmable pharmaceutical compositions for chrono drug release
Grant 10,980,738 - Vaka , et al. April 20, 2
2021-04-20
Opioid agonist / antagonist combination dosage forms
Grant 10,960,001 - Shah , et al. March 30, 2
2021-03-30
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,952,957 - Shah , et al. March 23, 2
2021-03-23
Extended Release Compositions Comprising Pyridostigmine
App 20210069117 - Vaka; Siva Ram Kiran ;   et al.
2021-03-11
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20210052487 - Shah; Navnit H. ;   et al.
2021-02-25
Extended release compositions comprising pyridostigmine
Grant 10,925,833 - Shelke , et al. February 23, 2
2021-02-23
Gastroretentive dosage forms for sustained drug delivery
Grant 10,918,597 - Meghpara , et al. February 16, 2
2021-02-16
Extended Release Compositions Comprising Trihexyphenidyl
App 20210038523 - Shelke; Namdev B. ;   et al.
2021-02-11
Extended Release Compositions Comprising Trihexyphenidyl
App 20210038524 - Shelke; Namdev B. ;   et al.
2021-02-11
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210030685 - Vaka; Siva Ram Kiran ;   et al.
2021-02-04
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20210022999 - Meghpara; Kanji ;   et al.
2021-01-28
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,898,430 - Shah , et al. January 26, 2
2021-01-26
Programmable pharmaceutical compositions for chrono drug release
Grant 10,898,431 - Vaka , et al. January 26, 2
2021-01-26
Extended release compositions comprising pyridostigmine
Grant 10,881,617 - Vaka , et al. January 5, 2
2021-01-05
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200405626 - Vaka; Siva Ram Kiran ;   et al.
2020-12-31
Extended release compositions comprising trihexyphenidyl
Grant 10,869,839 - Shelke , et al. December 22, 2
2020-12-22
Extended Release Compositions Comprising Pyridostigmine
App 20200383923 - Shelke; Namdev B. ;   et al.
2020-12-10
Gastroretentive dosage forms for sustained drug delivery
Grant 10,857,098 - Meghpara , et al. December 8, 2
2020-12-08
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,849,846 - Shah , et al. December 1, 2
2020-12-01
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20200337998 - Meghpara; Kanji ;   et al.
2020-10-29
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200330368 - Shah; Navnit H. ;   et al.
2020-10-22
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20200261359 - Meghpara; Kanji ;   et al.
2020-08-20
Extended Release Compositions Comprising Trihexyphenidyl
App 20200261372 - Shelke; Namdev B. ;   et al.
2020-08-20
Abuse-resistant drug formulations
Grant 10,744,131 - Sandhu , et al. A
2020-08-18
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,744,083 - Shah , et al. A
2020-08-18
Extended release compositions comprising pyridostigmine
Grant 10,744,093 - Vaka , et al. A
2020-08-18
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200253861 - Kind Code
2020-08-13
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200179267 - Shah; Navnit H. ;   et al.
2020-06-11
Extended Release Compositions Comprising Pyridostigmine
App 20200163889 - Vaka; Siva Ram Kiran ;   et al.
2020-05-28
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200155446 - Shah; Navnit H. ;   et al.
2020-05-21
Abuse-resistant drug formulations with built-in overdose protection
Grant 10,632,113 - Vaka , et al.
2020-04-28
Extended release compositions comprising pyridostigmine
Grant 10,588,863 - Vaka , et al.
2020-03-17
Extended Release Compositions Comprising Pyridostigmine
App 20190388351 - Vaka; Siva Ram Kiran ;   et al.
2019-12-26
Extended Release Compositions Comprising Pyridostigmine
App 20190374473 - Vaka; Siva Ram Kiran ;   et al.
2019-12-12
Supersaturated stabilized nanoparticles for poorly soluble drugs
Grant 10,500,282 - Desai , et al. Dec
2019-12-10
Opioid Agonist / Antagonist Combination Dosage Forms
App 20190358221 - Shah; Navnit H. ;   et al.
2019-11-28
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20190343957 - Vaka; Siva Ram Kiran ;   et al.
2019-11-14
Extended Release Drug Formulation With Overdose Protection And Abuse Deterrence
App 20190282508 - Shah; Navnit H. ;   et al.
2019-09-19
Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
Grant 10,406,234 - Vaka , et al. Sept
2019-09-10
Compositions And Uses Thereof
App 20190241557 - Desai; Dipen ;   et al.
2019-08-08
Orally Disintegrating Tablet Formulation For Enhanced Bioavailability
App 20190083403 - Djordjevic; Jelena ;   et al.
2019-03-21
Overdose Protection And Abuse Deterrent Immediate Release Drug Formulation
App 20190054031 - Shah; Navnit H. ;   et al.
2019-02-21
Orally disintegrating tablet formulation for enhanced bioavailability
Grant 10,195,150 - Djordjevic , et al. Fe
2019-02-05
Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof
App 20190030006 - Shah; Navnit H. ;   et al.
2019-01-31
Enhanced Abuse-deterrent Formulations Of Oxycodone
App 20180303757 - Banerjee; Siddhartha ;   et al.
2018-10-25
Food Independent Immediate Release Drug Formulation With Abuse Deterrence And Overdose Protection
App 20180296486 - Shah; Navnit H. ;   et al.
2018-10-18
Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof
Grant 10,034,865 - Shah , et al. July 31, 2
2018-07-31
Compositions And Uses Thereof
App 20180111930 - Desai; Dipen ;   et al.
2018-04-26
Solid Pharmaceutical Composition Comprising PI3K-Inhibitor
App 20170209455 - Desai; Dipen ;   et al.
2017-07-27
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20170173157 - VAKA; Siva Ram Kiran ;   et al.
2017-06-22
Compositions and uses thereof
Grant 9,663,517 - Desai , et al. May 30, 2
2017-05-30
Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof
App 20170071915 - SHAH; NAVNIT H. ;   et al.
2017-03-16
Compositions And Uses Thereof
App 20160355513 - Desai; Dipen ;   et al.
2016-12-08
Self-nanoemulsion of poorly soluble drugs
Grant 9,511,078 - Desai , et al. December 6, 2
2016-12-06
Abuse-resistant Drug Formulations With Built-in Overdose Protection
App 20160346274 - Vaka; Siva Ram Kiran ;   et al.
2016-12-01
Abuse-resistant Drug Formulations
App 20160317530 - Sandhu; Harpreet Kaur ;   et al.
2016-11-03
Compositions and uses thereof
Grant 9,447,089 - Desai , et al. September 20, 2
2016-09-20
Self-nanoemulsion Of Poorly Soluble Drugs
App 20160151392 - Desai; Dipen ;   et al.
2016-06-02
Orally Disintegrating Tablet Formulation For Enhanced Bioavailability
App 20160120809 - Djordjevic; Jelena ;   et al.
2016-05-05
Supersaturated Stabilized Nanoparticles For Poorly Soluble Drugs
App 20150335753 - Desai; Dipen ;   et al.
2015-11-26
Pharmaceutical Composition With Improved Bioavailability, Safety And Tolerability
App 20140128431 - Anand; Shalini M. ;   et al.
2014-05-08
Process For Controlled Crystallization Of An Active Pharmaceutical Ingredient From Supercooled Liquid State By Hot Melt Extrusion
App 20120213827 - Chatterji; Ashish ;   et al.
2012-08-23
Compositions and Uses Thereof
App 20100310659 - Desai; Dipen ;   et al.
2010-12-09
Colon-targeted delivery system
Grant 5,482,718 - Shah , et al. January 9, 1
1996-01-09
Pharmaceutical compositions with constant erosion volume for zero order controlled release
Grant 5,393,765 - Infeld , et al. February 28, 1
1995-02-28
Controlled release compositions with zero order release
Grant 4,892,742 - Shah January 9, 1
1990-01-09
Prostaglandin compositions
Grant 4,310,543 - Gallo-Torres , et al. January 12, 1
1982-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed